Cargando…

Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality

Bispecific antibodies (BsAbs) represent an important advance in innovative therapeutic strategies. Among the countless formats of BsAbs, fusion with molecules such as anticalins linked to a monoclonal antibody (mAb), represents an easy and low-cost way to obtain innovative molecules. We fused an ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aubrey, Nicolas, Gouilleux-Gruart, Valérie, Dhommée, Christine, Mariot, Julie, Boursin, Fanny, Albrecht, Nicolas, Bergua, Cécile, Croix, Cécile, Gilotin, Mäelle, Haudebourg, Eloi, Horiot, Catherine, Matthias, Laetitia, Mouline, Caroline, Lajoie, Laurie, Munos, Audrey, Ferry, Gilles, Viaud-Massuard, Marie-Claude, Thibault, Gilles, Velge-Roussel, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397084/ https://www.ncbi.nlm.nih.gov/pubmed/35997348 http://dx.doi.org/10.3390/antib11030054

Ejemplares similares

Tethering Innate Surface Receptors on Dendritic Cells: A New Avenue for Immune Tolerance Induction?
por: Lamendour, Lucille, et al.
Publicado: (2020)

The neonatal Fc receptor expression during macrophage differentiation is related to autophagy
por: Lamamy, Juliette, et al.
Publicado: (2022)

Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation
por: Meley, Daniel, et al.
Publicado: (2017)

Contribution of Intrinsic Fluorescence to the Design of a New 3D-Printed Implant for Releasing SDABS
por: Nicolas, Alexandre, et al.
Publicado: (2020)

Anticalin(®) Proteins as Therapeutic Agents in Human Diseases
por: Rothe, Christine, et al.
Publicado: (2018)

Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
por: Thibault, Gilles, et al.
Publicado: (2021)

Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs)
por: Jolivet, Louis, et al.
Publicado: (2022)

In Vitro Characterization and Stability Profiles of Antibody–Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation
por: Martin, Camille, et al.
Publicado: (2019)

New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation
por: Oyallon, Bruno, et al.
Publicado: (2021)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
por: Castaneda, Diana Cadena, et al.
Publicado: (2018)

A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells
por: Brachet-Botineau, Marie, et al.
Publicado: (2019)

Mapping Mechanostable Pulling Geometries of a Therapeutic Anticalin/CTLA-4 Protein Complex
por: Liu, Zhaowei, et al.
Publicado: (2021)

Oxidative metabolism in cancer: A STAT affair?
por: Bourgeais, Jérome, et al.
Publicado: (2013)

FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
por: Bequignon, Emilie, et al.
Publicado: (2019)

Multimodality Multiparametric Imaging of Early Tumor Response to a Novel Antiangiogenic Therapy Based on Anticalins
por: Meier, Reinhard, et al.
Publicado: (2014)

High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide
por: Rauth, Sabine, et al.
Publicado: (2016)

Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins
por: Achatz, S., et al.
Publicado: (2021)

Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences
por: Cnudde, Thomas, et al.
Publicado: (2020)

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)

Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice
por: Deuschle, Friedrich‐Christian, et al.
Publicado: (2020)

Development of a high affinity Anticalin(®) directed against human CD98hc for theranostic applications
por: Deuschle, Friedrich-Christian, et al.
Publicado: (2020)

Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension Domains
por: Siegemund, Martin, et al.
Publicado: (2021)

VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines
por: El Dor, Maya, et al.
Publicado: (2020)

Finding the Right Heavy Chains for Immunostimulatory Antibodies
por: Boulard, Pierre, et al.
Publicado: (2022)

Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France
por: Martin, Camille, et al.
Publicado: (2018)

α-Lithiation and Electrophilic Substitution of 1,4,4-Trimethyl-3,4-dihydroquinolin-2-one
por: Sébastien, Bouclé, et al.
Publicado: (2010)

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019)

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
por: Ramdani, Yanis, et al.
Publicado: (2022)

First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors
por: Mross, Klaus, et al.
Publicado: (2013)

STAT5A/5B-specific expansion and transformation of hematopoietic stem cells
por: Ghanem, S, et al.
Publicado: (2017)

Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56(dim) Natural Killer Cells
por: Lajoie, Laurie, et al.
Publicado: (2017)

Supernatant from Bifidobacterium Differentially Modulates Transduction Signaling Pathways for Biological Functions of Human Dendritic Cells
por: Hoarau, Cyrille, et al.
Publicado: (2008)

4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis
por: Granel, Jérôme, et al.
Publicado: (2020)

The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020)

Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis
por: Dalloneau, Emilie, et al.
Publicado: (2016)

Structure of the human heterodimeric transporter 4F2hc-LAT2 in complex with Anticalin, an alternative binding protein for applications in single-particle cryo-EM
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2022)

“Ways in which the neonatal Fc-receptor is involved in autoimmunity”
por: Lamamy, Juliette, et al.
Publicado: (2021)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
por: Dumet, Christophe, et al.
Publicado: (2023)

Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule
por: Gatault, Philippe, et al.
Publicado: (2015)

Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody–Drug Conjugates
por: Feuillâtre, Ofelia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gqdcelpgmk83nqm4kho3n1h2tb